NCT06641596View on ClinicalTrials.gov

Impact of Chromium, Phyllanthus Emblica, and Shilajit on Cardiovascular Health, Fitness, and Weight Loss During Exercise and Diet Programs

NACompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

January 30, 2024

Study Completion Date

May 29, 2024

Conditions
OverweightMetabolic Syndrome X
Interventions
DIETARY_SUPPLEMENT

Placebo

2 capsules of Placebo, once daily after breakfast for 12 weeks

DIETARY_SUPPLEMENT

Cr-400

1 capsule of Cr-400 + 1 capsule of Placebo, once a day after breakfast for 12 weeks

DIETARY_SUPPLEMENT

Cr-800

2 capsules of Cr-400, once a day after breakfast for 12 weeks

DIETARY_SUPPLEMENT

PE-500

1 capsule of PE + 1 capsule of Placebo, once a day after breakfast for 12 weeks

DIETARY_SUPPLEMENT

PE-1000

2 capsules of PE-500, once a day after breakfast for 12 weeks

Trial Locations (1)

77843

Texas A&M University, College Station

All Listed Sponsors
lead

Kerry Group P.L.C

INDUSTRY

NCT06641596 - Impact of Chromium, Phyllanthus Emblica, and Shilajit on Cardiovascular Health, Fitness, and Weight Loss During Exercise and Diet Programs | Biotech Hunter | Biotech Hunter